02192nas a2200217 4500008004100000245014600041210006900187260001300256300000900269490000600278520142400284653002601708653002201734653003301756653006501789100001801854700001801872700001801890700001801908856004801926 2022 eng d00aAn Overview of Spontaneous Reporting, Targeted Spontaneous Reporting and Cohort Event Monitoring-Pharmacovigilance Methods: Myths and Facts0 aOverview of Spontaneous Reporting Targeted Spontaneous Reporting cMay 2022 a8-130 v83 a
Adverse drug reaction (ADR) reporting is an important safety concern to monitor safety among the patient. Pharmacovigilance (PV) is usually involves in detection of spontaneous adverse reaction, therefore these shall be submitted to the National Coordination Centre Pharmacovigilance programme of India (NCC-PVPI) which is located at Ghaziabad functioning under ministry of health and family welfare, Government of India. ADR is a global concern that causes serious impact on consumers both in terms of health and financial aspects. Hence monitoring of these adverse reactions is utmost important attribute to enhance patient safety. Perhaps, India is adopting spontaneous reporting (SR) system since 1998, henceforth targeted spontaneous reporting (TSR) system came into consideration in 2010, and that is a complimentary method to spontaneous reporting. This system is useful to establish evidence-based reports generation of specific drug and ADR combination, increase alertness and also helpful in recognizing harmful risks The main aim of this article is to encourage evidence-based decision making to enhance patient safety. In addition to this, establish a functional reporting system i.e. targeted spontaneous reporting system to monitor the safety of targeted medicines and to learn more about the safety profile of new medicines in the early post marketing phase in our population.
10aAdverse drug reaction10aPharmacovigilance10aSpontaneous reporting system10aTargeted spontaneous reporting and cohort event monitoring.1 aThota, Prasad1 aThota, Anusha1 aSarma, Phulen1 aMedhi, Bikash uhttps://www.jppcm.org/article/2022/8/1/8-13